Taken together, these data indicate that a complex formed by oncogenic transcription factors/co-factors may play a direct role in splicing modulation, further expanding the suggestion that targeting the AURKA-hnRNPK axis is a possible therapeutic intervention to improve the prognosis of patients with breast cancer. This evidence concerns the gene AURKA and breast carcinoma.